跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-005
首页
药物
AT-005
AT-005
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
STAT3 inhibiting compositions and methods
US 8058316 B2
申请人: FARJO RAFAL A
优先权: 2010
US
2 件公开
Inhibitors of MEMAPSIN2 and use thereof
CN 100590132 C
申请人: OKLAHOMA MED RES FOUND
优先权: 2000
CN
Inhibitors of memapsin 2 and use thereof
US 2003092629 A1
申请人: OKLAHOMA MED RES FOUND
优先权: 2001
US
Application of heat-resistant lactobacillus fermentum in preparation of defecation promoting food or drugs
CN 113508907 A
申请人: HIGH CHANGE SHENYANG CHILDRENS PRODUCTS CO LTD
优先权: 2021
CN
Chuzhou chrysanthemum formula granules and preparation method thereof
CN 116549400 A
申请人: ANHUI JIUHUA & HUAYUAN PHARMACEUTICAL CO LTD
优先权: 2023
CN
TREATMENT OF DISEASES ASSOCIATED WITH REDUCTIVE STRESS
US 20250262189 A1
申请人: INABA TARO
优先权: 2023
US
Yarrowia lipolytica engineering bacterium for producing esterified astaxanthin as well as construction method and application thereof
CN 120944726 A
申请人: UNIV EAST CHINA SCIENCE & TECH
优先权: 2025
CN
Method for synthesizing ascorbyl glucoside through conversion of yeast lysate and application of ascorbyl glucoside
CN 122303062 A
申请人: GUANGZHOU HUAJIAO BIO TECH CO LTD
优先权: 2026
CN
Preparation method and application of bifid yeast and feijoa ferment with whitening, anti-aging and anti-inflammatory effects
CN 122297358 A
申请人: GUANGZHOU HUAJIAO BIO TECH CO LTD
优先权: 2026
CN
药物
反馈